• Home
  • News & IR
  • News
Bio Vaccine
Is mRNA the Future of Drug Development?
2021-10-19
Bio Vaccine
Should you mix and match COVID-19 vaccines? Experts weigh in.
2021-10-18
Bio Vaccine
기술 확보 나선 mRNA…원부자재 국산화 숙제
2021-10-17
Digital Therapeutics
‘디지털 치료제’ 새 패러다임 될까?
2021-10-08
Bio Vaccine
테라젠바이오•엔에이백신연구소, 항암백신 개발 협력
2021-09-28
Digital Therapeutics
"게임ㆍ앱으로 조현병, 고혈압 치료"…‘디지털 치료제’ 상용화 속도
2021-09-23
Investment
Through CEO of Hanmi Science, CancerRop Issues KRW 20 Billion New Shares for Cooperation with Oxford Vacmedix
2021-08-31
Investment
인천경제청 바이오헬스 비즈니스 생태계 조성 총력
2021-08-31
Digital Therapeutics
FDA, 뇌졸증 회복 돕는 '디지털 치료제' 승인
2021-08-30
  1.   
  2. 35
  3. 36
  4. 37
  5. 38
  6. 39
  7. 40
  8. 41
  9.   
  • 10F, 173, Digital-ro, Geumcheon-gu, Seoul (Gasan-dong, Elysian)
  • Tel : 02-890-8700
  • IR Service : 02-6964-8770
  • Fax : 02-6964-8755

About Us

Goals & Promise

Leadership

Company History

IR

Notice & IR

Disclosure Information

Dx&Vx 2023 Award Impact

Contact

Private Policy Terms of Use twitter icon @dxvx_official
© 2024 Dx&Vx. All Rights Reserved.